Overactive bladder in the male patient: Bladder, outlet, or both?

被引:39
作者
Abdel-Aziz K.F. [1 ]
Lemack G.E. [1 ]
机构
[1] Department of Urology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, 75390-9110, TX
关键词
Benign Prostatic Hyperplasia; Detrusor Overactivity; Lower Urinary Tract Symptom; Overactive Bladder; Tamsulosin;
D O I
10.1007/s11934-002-0095-3
中图分类号
学科分类号
摘要
Generations of urologists have presumed that the cause of lower urinary tract symptoms (LUTS) in men is infravesical (prostatic) obstruction. When symptoms such as urinary urgency and frequency can’t easily be explained directly by obstruction, secondary effects of obstruction on the bladder are identified as causative factors. Although to some extent this explanation may still be accurate, emerging concepts in the pathophysiology of LUTS in men may be at odds with these traditional explanations. The idea that primary bladder pathology may explain the symptom complex in at least one subset of men with LUTS has both experimental and clinical support. This review discusses the physiologic and clinical observations used to explain the mechanisms underlying LUTS. Specifically, this review focuses on two data sets: one supporting infravesical obstruction as the causative factor for LUTS, and another positing that a primary bladder abnormality is responsible. © 2002, Current Science Inc.
引用
收藏
页码:445 / 451
页数:6
相关论文
共 53 条
  • [1] Madersbacher S., Hidinger G., Temml C., Schmidbauer C.P., Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men, Eur Urol, 24, pp. 136-141, (1998)
  • [2] Yalla S.V., Sullivan M.P., Lecamwasam H.S., Et al., Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism, J Urol, 153, pp. 674-680, (1995)
  • [3] Blaivas J.G., Pathophysiology and differential diagnosis of benign prostatic hypertrophy, Urology, 32, pp. 5-11, (1988)
  • [4] Milsom I., Abrams P., Cardozo L., Et al., How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study, BJU Int, 87, pp. 760-766, (2001)
  • [5] Andersen J.T., Nordling J., Walter S., Prostatism I: the correlation between symptoms, cystometric, and urodynamic findings, Scand J Urol Nephrol, 13, pp. 229-236, (1979)
  • [6] Andersen J.T., Jacobsen O., Worm-Petersen J., Et al., Bladder function in healthy elderly males, Scand J Urol Nephrol, 12, pp. 123-127, (1978)
  • [7] Christensen M.M., Bruskewitz R.C., Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention, Urol Clin North Am, 17, pp. 509-516, (1990)
  • [8] Finkbeiner A., Lapides J., Effect of distension on blood flow in dog’s urinary bladder, Invest Urol, 12, pp. 210-212, (1974)
  • [9] Lin A.T.L., Chen M.T., Yang C.H., Blood flow of the urinary bladder effects of outlet obstruction and correlation with energetic metabolism, J Urol, 149, pp. 285-292, (1993)
  • [10] Lemack G.E., Burckard F., Zimmern P.E., Et al., Physiologic sequelae of partial infravesical obstruction in the mouse: role of inducible nitric oxide synthase, J Urol, 161, pp. 1015-1022, (1999)